Effects and safety profile of betahistine in patients in the Russian contingent of OSVaLD, an open-label observational study in vestibular vertigo

BACKGROUND: We report here data from the >200 patients recruited in Russia to take part in OSVaLD, a 12-week, open-label, post-marketing surveillance study of the response to betahistine 48 mg/day in vertigo of peripheral vestibular origin carried out in a total of 13 countries. METHODS: The prim...

Descripción completa

Detalles Bibliográficos
Autores principales: Morozova, Svetlana Vyacheslavovna, Alekseeva, Natalia Stepanovna, Lilenko, Sergey Vasilyevich, Matsnev, Eduard Ivanovich, Melnikov, Oleg Anatol’evich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310344/
https://www.ncbi.nlm.nih.gov/pubmed/25653552
http://dx.doi.org/10.2147/IJGM.S73842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310344/
https://www.ncbi.nlm.nih.gov/pubmed/25653552
http://dx.doi.org/10.2147/IJGM.S73842

Ejemplares similares